Clinical trial for Mitochondrial Respiratory Chain Diseases

January 26, 2012 in News by Yurina Ichikawa

A link about the clinical trial led by Principal Investigator Dr. Gregory Enns (Stanford University). The purpose of this trial is to test the safety and efficacy of the drug, EPI-743, in patients affected with mitochondrial respiratory chain diseases. The trial is currently in phase II.